| Oct 1 |
IGM Biosciences Stock Drops Sharply on ‘Pipeline Transformation’ to Autoimmune Diseases
|
| Oct 1 |
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
|
| Sep 30 |
IGM Biosciences to minimize spending on oncology candidates, appoints new CEO
|
| Sep 30 |
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
|
| Sep 27 |
While shareholders of IGM Biosciences (NASDAQ:IGMS) are in the black over 1 year, those who bought a week ago aren't so fortunate
|
| Sep 18 |
IGM Biosciences: Waiting For Godot
|
| Sep 18 |
IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains?
|
| Sep 10 |
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
|
| Aug 22 |
All You Need to Know About IGM Biosciences (IGMS) Rating Upgrade to Buy
|
| Aug 14 |
IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Lags Revenue Estimates
|
